Loading clinical trials...
Loading clinical trials...
Phase II/III Clinical Trial of NPC-15 - Verification of the Efficacy for Sleep Disorders of Children With Autism Spectrum Disorders -
Conditions
Interventions
NPC-15 Granules Lower Dose
NPC-15 Granules Higher Dose
+1 more
Start Date
June 16, 2016
Primary Completion Date
September 1, 2018
Completion Date
September 14, 2018
Last Updated
April 16, 2019
NCT06290258
NCT05750095
NCT07426991
NCT05874466
NCT06712784
NCT05754073
Lead Sponsor
Nobelpharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions